Connect Biopharma Holdings Limited (CNTB) — Stock Score Summary

Connect Biopharma Holdings Limited (CNTB) has a MoatMap StockRank of 11/100 based on Quality (24/100), Value (33/100), and Momentum (37/100) factor scores. The current signal is STRONG SELL. Connect Biopharma is a clinical-stage biopharmaceutical company with no commercialized products or steady cash flows. It does not possess the regulatory or manufacturing moats of a high-quality CDMO.

Connect Biopharma Holdings is a clinical-stage biotechnology company dedicated to developing innovative therapies for chronic inflammatory diseases, primarily in immunology. Its pipeline includes novel small molecule and antibody drug candidates designed to modulate specific immune pathways to address unmet medical needs. The company's future growth hinges on the successful advancement and commercialization of its clinical assets.

Key Financial Metrics

Price$2.15
Market Cap$150M
P/E (Forward)-2.42
Price/Book3.53
Return on Equity-102.9%
Return on Invested Capital-136.8%
Debt/Equity1.63
Gross Margin100.0%
Operating Margin-11601.8%
Free Cash Flow$-34M

Connect Biopharma Holdings Limited operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Connect Biopharma Holdings Limited’s (CNTB) StockRank?
MoatMap’s StockRank for Connect Biopharma Holdings Limited (CNTB) is 11/100, with a Strong Sell signal. It is a composite of Quality (24), Value (33), and Momentum (37) factor ranks across MoatMap’s 19,000+ stock universe.
Does Connect Biopharma Holdings Limited have an economic moat?
Connect Biopharma Holdings Limited (CNTB) has a Quality factor score of 24/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Connect Biopharma Holdings Limited a buy, hold, or sell?
MoatMap’s current signal for Connect Biopharma Holdings Limited (CNTB) is Strong Sell, based on a StockRank of 11/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Connect Biopharma Holdings Limited in?
Connect Biopharma Holdings Limited (CNTB) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksCNTB deep dive reportAI ChampionsHow we score stocksSense-check another stock